Epiflo

DEVICE5 trials

Conditions

Anorectal SurgeriesComplication of Surgical ProcedureDiabetic Foot UlcersIncisionInstrumented Spinal FusionLower ExtremityRevascularizationSurgical Wound Healing

Phase 2

Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers

CompletedNCT01291160

Neogenix, LLC dba OgenixDiabetic Foot Ulcers

Start: 2009-10-31End: 2013-02-28Updated: 2014-05-13

TCOT Effectiveness in Preventing Wound Infections in Perineal Resections

WithdrawnNCT02374294

Neogenix, LLC dba OgenixComplication of Surgical Procedure

Start: 2015-09-30End: 2015-09-30Updated: 2015-09-30

Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery

WithdrawnNCT02617706

Neogenix, LLC dba OgenixAnorectal Surgeries

Start: 2017-01-31End: 2019-01-31Updated: 2017-08-14

Unknown Phase

Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion

WithdrawnNCT02615379

Neogenix, LLC dba OgenixInstrumented Spinal Fusion

Start: 2017-07-01End: 2019-03-31Updated: 2017-08-14

Oxygen for Vascular Incisional Healing

NCT03746132

Neogenix, LLC dba OgenixIncision, Lower Extremity, Revascularization +1

Start: 2019-03-07End: 2022-07-31Target: 100Updated: 2021-09-09

Epiflo

Sponsors

Conditions

Phase 2

Unknown Phase